COMPARISON OF INFLAMMATORY MARKERS BETWEEN COVID VACCINATED POPULATION AND NATURALLY INFECTED POPULATION

The 2019 coronavirus disease (COVID-19) pandemic poses formidable obstacles in the fields of medicine, science, and public health. SARS-CoV-2 is a coronavirus that causes severe acute respiratory syndrome and may spread fast, with potentially fatal consequences. Establishing reliable laboratory biomarkers capable of risk-based patient classification is crucial for ensuring timely therapy. The study focuses on the problems of the COVID‐19 vaccine and multisystem inflammatory syndrome. Multi-organ failure in patients with severe COVID-19 consequences is mostly caused by systemic vasculitis and cytokine-mediated coagulation abnormalities, as shown by a review of recently published data. In addition, the study examines biomarkers associated with COVID-19 disease progression. Lastly, the study focuses on Pro-Inflammatory Cytokines (Il-1 and Il-6) And Lung Inflammation by Coronavirus-19 and its Anti-Inflammatory Strategies.